Search research articles
Contact Us
Filters
Showing results (61-70 of 144) with videos related to
Page
of 15
Sort By:
Scientific Reports
|
September 2, 2020
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
Kimberley Steeds, Yper Hall, Gillian S Slack, et al.
Vaccine
|
September 17, 2019
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
Rob J Noad, Karl Simpson, Anthony R Fooks, et al.
Genome Biology
|
September 7, 2020
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease
Xiaofeng Dong, Jordana Munoz-Basagoiti, Natasha Y Rickett, et al.
The Journal of Infectious Diseases
|
December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology
Kathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Frontiers in Immunology
|
September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
Stephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Genome Biology
|
November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
Stuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma
Jeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
The Journal of Infectious Diseases
|
December 31, 2015
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
Stuart David Dowall, Jo Callan, Antra Zeltina, et al.
Emerging Infectious Diseases
|
January 24, 2023
Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
Stephanie Longet, Cristina Leggio, Joseph Akoi Bore, et al.
The Lancet. Microbe
|
November 16, 2024
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Xin Hui S Chan, Ilsa L Haeusler, Bennett J K Choy, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 144) with videos related to
Sort By:
Page
of 15
Scientific Reports
|
September 2, 2020
Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
Kimberley Steeds, Yper Hall, Gillian S Slack, et al.
Vaccine
|
September 17, 2019
UK vaccines network: Mapping priority pathogens of epidemic potential and vaccine pipeline developments
Rob J Noad, Karl Simpson, Anthony R Fooks, et al.
Genome Biology
|
September 7, 2020
Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease
Xiaofeng Dong, Jordana Munoz-Basagoiti, Natasha Y Rickett, et al.
The Journal of Infectious Diseases
|
December 11, 2021
Sequential Delivery of Live Attenuated Influenza Vaccine and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Ferret Model Can Reduce SARS-CoV-2 Shedding and Does Not Result in Enhanced Lung Pathology
Kathryn A Ryan, Katarzyna E Schewe, Jonathan Crowe, et al.
Frontiers in Immunology
|
September 26, 2022
mRNA vaccination drives differential mucosal neutralizing antibody profiles in naïve and SARS-CoV-2 previously-infected individuals
Stephanie Longet, Alexander Hargreaves, Saoirse Healy, et al.
Genome Biology
|
November 23, 2014
Elucidating variations in the nucleotide sequence of Ebola virus associated with increasing pathogenicity
Stuart D Dowall, David A Matthews, Isabel Garcia-Dorival, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 5, 2005
Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma
Jeremy P Braybrooke, Andrew Slade, Gael Deplanque, et al.
The Journal of Infectious Diseases
|
December 31, 2015
Development of a Cost-effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection
Stuart David Dowall, Jo Callan, Antra Zeltina, et al.
Emerging Infectious Diseases
|
January 24, 2023
Influence of Landscape Patterns on Exposure to Lassa Fever Virus, Guinea
Stephanie Longet, Cristina Leggio, Joseph Akoi Bore, et al.
The Lancet. Microbe
|
November 16, 2024
Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials
Xin Hui S Chan, Ilsa L Haeusler, Bennett J K Choy, et al.
Page
of 15